Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021

Q Wu, W Qian, X Sun, S Jiang - Journal of hematology & oncology, 2022 - Springer
Abstract The United States Food and Drug Administration (US FDA) has always been a
forerunner in drug evaluation and supervision. Over the past 31 years, 1050 drugs …

Targeted therapy for advanced thyroid cancer: kinase inhibitors and beyond

ME Cabanillas, M Ryder, C Jimenez - Endocrine reviews, 2019 - academic.oup.com
The treatment of advanced thyroid cancer has undergone rapid evolution in the last decade,
with multiple kinase inhibitor drug approvals for each subtype of thyroid cancer and a …

FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner

J Huang, W Sun, Z Wang, C Lv, T Zhang… - Journal of Experimental …, 2022 - Springer
Abstract Background N6-methyladenosine (m6A) modification is the most common chemical
modification in mammalian mRNAs, and it plays important roles by regulating several …

Global burden of thyroid cancer from 1990 to 2017

YJ Deng, HT Li, M Wang, N Li, T Tian, Y Wu… - JAMA network …, 2020 - jamanetwork.com
Importance Thyroid cancer is the most pervasive endocrine cancer worldwide. Studies
examining the association between thyroid cancer and country, sex, age, sociodemographic …

Review of deep learning approaches for thyroid cancer diagnosis

S Anari, N Tataei Sarshar, N Mahjoori… - Mathematical …, 2022 - Wiley Online Library
Thyroid nodule is one of the common life‐threatening diseases, and it had an increasing
trend over the last years. Ultrasound imaging is a commonly used diagnostic method for …

Active surveillance versus thyroid surgery for differentiated thyroid cancer: a systematic review

R Chou, T Dana, M Haymart, AM Leung, RP Tufano… - Thyroid, 2022 - liebertpub.com
Background: Active surveillance has been proposed as an appropriate management
strategy for low-risk differentiated thyroid cancer (DTC), due to the typically favorable …

Pathogenesis of cancers derived from thyroid follicular cells

JA Fagin, GP Krishnamoorthy, I Landa - Nature reviews Cancer, 2023 - nature.com
The genomic simplicity of differentiated cancers derived from thyroid follicular cells offers
unique insights into how oncogenic drivers impact tumour phenotype. Essentially, the main …

Cancer in Africa: the untold story

Y Hamdi, I Abdeljaoued-Tej, AA Zatchi… - Frontiers in …, 2021 - frontiersin.org
Background Despite rising incidence and mortality rates in Africa, cancer has been given
low priority in the research field and in healthcare services. Indeed, 57% of all new cancer …

Thyroid surgery for differentiated thyroid cancer—recent advances and future directions

TS Wang, JA Sosa - Nature Reviews Endocrinology, 2018 - nature.com
Population-based studies have demonstrated that an increasing number of incidental
thyroid nodules are being identified. The corresponding increase in thyroid-based …

[PDF][PDF] SNMMI procedure standard/EANM practice guideline for nuclear medicine evaluation and therapy of differentiated thyroid cancer: abbreviated version

AM Avram, L Giovanella, B Greenspan, SA Lawson… - 2022 - Soc Nuclear Med
Editor's note: SNMMI and the European Association of Nuclear Medicine periodically define
new standards/guidelines for nuclear medicine practice to help advance the science of …